Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters. In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the countryÂ’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack. Scope of the Report: This report focuses on the Biodefense in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the...